Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and...

Hydromer, Inc. Announces the Sale of the T-HEXX Animal Healthcare Product Line to Huvepharma Branchburg, NJ, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer, Inc. (HYDI.PK – OTC BB), the "Company" or "Hydromer", announces that Huvepharma has acquired its T-HEXX Animal...